Abstract
The aim of this study was to clarify the contribution of cytochrome P450 (CYP)-dependent metabolism of vitamin E isoforms to their tissue concentrations. We studied the effect of ketoconazole, a potent inhibitor of CYP-dependent vitamin E metabolism in cultured cells, on vitamin E concentration in rats. Vitamin E-deficient rats fed a vitamin E-free diet for 4 weeks were administered by oral gavage a vitamin E-free emulsion, an emulsion containing α-tocopherol, γ-tocopherol or a tocotrienol mixture with or without ketoconazole. α-Tocopherol was detected in the serum and various tissues of the vitamin E-deficient rats, but γ-tocopherol, α- and γ-tocotrienol were not detected. Ketoconazole decreased urinary excretion of 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman after α-tocopherol or a tocotrienol mixture administration, and that of 2,7,8-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman (γ-CEHC) after γ-tocopherol or a tocotrienol mixture administration. The γ-tocopherol, α- and γ-tocotrienol concentrations in the serum and various tissues at 24 h after their administration were elevated by ketoconazole, while the α-tocopherol concentration was not affected. The γ-tocopherol or γ-tocotrienol concentration in the jejunum at 3 h after each administration was also elevated by ketoconazole. In addition, significant amount of γ-CEHC was in the jejunum at 3 h after γ-tocopherol or γ-tocotrienol administration, and ketoconazole inhibited γ-tocopherol metabolism to γ-CEHC in the jejunum. These results showed that CYP-dependent metabolism of γ-tocopherol and tocotrienol is a critical determinant of their concentrations in the serum and tissues. The data also suggest that some amount of dietary vitamin E isoform is metabolized by a CYP-mediated pathway in the intestine during absorption.
Similar content being viewed by others
Abbreviations
- α-CEHC:
-
2,5,7,8-Tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman
- γ-CEHC:
-
2,7,8-Trimethyl-2(2′-carboxyethyl)-6-hydroxychroman
- CYP:
-
Cytochrome P450
- α-TTP:
-
α-Tocopherol transfer protein
References
Traber MG, Sies H (1996) Vitamin E in humans: demand and delivery. Annu Rev Nutr 16:321–347
Kayden HJ, Traber MG (1993) Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34:343–358
Abe C, Ikeda S, Uchida T, Yamashita K, Ichikawa T (2007) Triton WR1339, an Inhibitor of lipoprotein lipase, decreases vitamin E concentration in some tissues of rats by inhibiting its transport to liver. J Nutr 137:345–350
Traber MG, Arai H (1999) Molecular mechanisms of vitamin E transport. Annu Rev Nutr 19:343–355
Traber MG, Burton GW, Hamilton RL (2004) Vitamin E trafficking. Ann NY Acad Sci 1031:1–12
Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K (1997) Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105–108
Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R, Arai H, Inoue K, Mandel JL, Koenig M (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nat Genet 9:141–145
Leonard SW, Terasawa Y, Farese Jr RV, Traber MG (2002) Incorporation of deuterated RRR- or all-rac-α-tocopherol in plasma and tissues of α-tocopherol transfer protein-null mice. Am J Clin Nutr 75:555–560
Traber MG, Siddens LK, Leonard SW, Schock B, Gohil K, Krueger SK, Cross CE, Williams DE (2005) α-Tocopherol modulates Cyp3a expression, increases γ-CEHC production, and limits tissue γ-tocopherol accumulation in mice fed high γ-tocopherol diets. Free Radic Biol Med 38:773–785
Schultz M, Leist M, Petrzika M, Gassmann B, Brigelius-Flohé R (1995) Novel urinary metabolite of α-tocopherol, 2,5,7,8-tetramethyl-2(2′-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? Am J Clin Nutr 62:1527S–1534S
Swanson JE, Ben RN, Burton GW, Parker RS (1999) Urinary excretion of 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman is a major route of elimination of γ-tocopherol in humans. J Lipid Res 40:665–671
Lodge JK, Ridlington J, Leonard S, Vaule H, Traber MG (2001) α- and γ-Tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine. Lipids 36:43–48
Chiku S, Hamamura K, Nakamura T (1984) Novel urinary metabolite of d-δ-tocopherol in rats. J Lipid Res 25:40–48
Hattori A, Fukushima T, Imai K (2000) Occurrence and determination of a natriuretic hormone, 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman, in rat plasma, urine, and bile. Anal Biochem 281:209–215
Saito H, Kiyose C, Yoshimura H, Ueda T, Kondo K, Igarashi O (2003) γ-Tocotrienol, a vitamin E homolog, is a natriuretic hormone precursor. J Lipid Res 44:1530–1535
Birringer M, Pfluger P, Kluth D, Landes N, Brigelius-Flohé R (2002) Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 Cells. J Nutr 132:3113–3118
Parker RS, Sontag TJ, Swanson JE, McCormick C (2004) Discovery, characterization, and significance of the cytochrome P450 ω-hydroxylase pathway of vitamin E catabolism. Ann NY Acad Sci 1031:13–21
Sontag TJ, Parker RS (2002) Cytochrome P450 ω-hydroxylase pathway of tocopherol catabolism: novel mechanism of regulation of vitamin E status. J Biol Chem 277:25290–25296
Sheets JJ, Mason JI (1984) Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. Drug Metab Dispos 12:603–606
Parker RS, Sontag TJ, Swanson JE (2000) Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun 277:531–534
You C.-S, Sontag TJ, Swanson JE, Parker RS (2005) Long-chain carboxychromanols are the major metabolites or tocopherols and tocotrienols in A549 lung epithelial cells but not HepG2 cells. J Nutr 135:227–232
Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 Purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951
Ueda T, Igarashi O (1987) New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2,2,5,7,8-pentamethyl-6-chromanol as an internal standard. J Micronutr Anal 3:185–198
Kiyose C, Saito H, Kaneko K, Hamamura K, Tomioka M, Ueda T, Igarashi O (2001) α-Tocopherol affects the urinary and biliary excretion of 2,7,8-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman, γ-tocopherol metabolite, in rats. Lipids 36:467–472
Eagling VA, Tjia JF, Back DJ (1998) Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol 45:107–114
Kobayashi K, Urashima K, Shimada N, Chiba K (2003) Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat. Drug Metab Dispos 31:833–836
Abe C, Ikeda S, Yamashita K (2005) Dietary sesame seeds elevate α-tocopherol concentration in rat brain. J Nutr Sci Vitaminol 51:223–230
Sontag TJ, Parker RS (2007) Comparative influence of major structural features of tocopherols and tocotrienols on kinetics of their ω-oxidation by cellular and microsomal tocopherol-ω-hydroxylase. J Lipid Res. Epub ahead of print
Acknowledgments
This study was supported in part by Grant-in Aid for Scientific Research 15680018 from Japan Society for the Promotion of Science, Japan. The authors are grateful to Eisai Food & Chemical for their contribution of vitamin E isoforms and their metabolites, and to Hiroaki Oda for his assistance with animal experimentation.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Abe, C., Uchida, T., Ohta, M. et al. Cytochrome P450-Dependent Metabolism of Vitamin E Isoforms is a Critical Determinant of Their Tissue Concentrations in Rats. Lipids 42, 637–645 (2007). https://doi.org/10.1007/s11745-007-3064-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-007-3064-2